22 results
DEFR14A
QSI
Quantum-Si Incorporated - Ordinary Shares
29 Apr 24
Revised proxy
8:16pm
– Bioscience, and previously as Segment Market Manager and Product Manager Cell Analysis + Cell Culture Systems. Dr. Johnston received her Ph.D. in molecular … . LaPointe was General Counsel at Thrive Bioscience, Inc., a cell culture instruments and software company, from August 2014 to July 2019, General
8-K
EX-10.1
r3lyttdm9ryyvtc k6
2 May 23
Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer
8:21am
8-K
EX-10.1
s6ldx
4 Oct 22
Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer
8:16am
424B3
mq3yzc4jtmw6hyzdk
9 May 22
Prospectus supplement
4:24pm
424B3
qi1w5ozx
9 May 22
Prospectus supplement
4:21pm
8-K
EX-10.1
tfirs6i thwzb970c
9 May 22
Quantum-Si Reports First Quarter 2022 Financial Results
4:18pm
DEF 14A
fz80zzo o5dpbbs2
29 Mar 22
Definitive proxy
4:01pm
8-K
EX-99.1
8xxy1l8h
8 Mar 22
Quantum-Si Investor Update March 8 2022
2:10pm
424B3
bacscsdo96whomea
4 Mar 22
Prospectus supplement
4:02pm
POS AM
1cgln3d4
1 Mar 22
Prospectus update (post-effective amendment)
9:51pm
424B3
c7qgy
22 Jul 21
Prospectus supplement
6:02am